RSK1 Antibody [P7B9]

Catalog No.: F4614

    Application: Reactivity:
    • Lane 1: A431, Lane 2: K562, Lane 3: Jurkat, Lane 4: COS-7
    1/

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:50
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat, Monkey, Bovine, Pig
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    90 kDa
    ポジティブコントロール A-431 cells; A549 cells; K-562 cells; Jurkat cells; COS-7 cells; Vero cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    RSK1 Antibody [P7B9] detects endogenous levels of total RSK1 protein.
    タンパク質の局在
    細胞質、細胞核
    Uniprot ID
    Q15418
    Clone
    P7B9
    Synonym(s)
    Ribosomal protein S6 kinase alpha-1; S6K-alpha-1; RPS6KA1; 90 kDa ribosomal protein S6 kinase 1 (p90-RSK 1; p90RSK1; p90S6K); MAPK-activated protein kinase 1a; MAPKAP kinase 1a; MAPKAPK-1a; Ribosomal S6 kinase 1; RSK-1; MAPKAPK1A; RSK1
    Background
    RSK1 (ribosomal S6 kinase 1) is a serine/threonine kinase that serves as a key effector of the ERK/MAPK signaling pathway and is characterized by its two kinase domains: an N-terminal kinase domain (NTKD) and a C-terminal kinase domain (CTKD). The NTKD features a bilobal fold with a disordered activation loop and αC-helix in its inactive form, while the CTKD contains an ERK-docking D-domain and critical phosphorylation sites (Thr573/Ser380 in CTKD, Thr359/Ser363 in the linker region). Activation of RSK1 occurs sequentially: ERK1/2 first docks at the D-domain to phosphorylate CTKD Thr573, which then triggers autophosphorylation at the NTKD hydrophobic motif Ser380 and PDK1-mediated phosphorylation at Thr359/Ser363, aligning catalytic spines and exposing the NTKD active site for substrate access. Fully activated RSK1 utilizes a C-terminal docking motif to recruit substrates, with the NTKD phosphorylating targets such as ribosomal S6 (enhancing 5'TOP mRNA translation and ribosome biogenesis), Mcl-1/Mdm2 (promoting anti-apoptotic Bcl-2 stabilization and p53 degradation), TSC2/raptor (activating mTORC1 to stimulate protein synthesis), and cytoskeletal effectors like filamin A, LIMK, and cofilin (driving actin remodeling for cell motility and invasion). PI3K/mTOR signaling provides additional input at Ser380, amplifying growth factor-driven responses, while negative regulation is mediated by PP2C/PP1 phosphatases and S100B inhibition at the ERK-docking interface. Hyperactivation of RSK1 is implicated in cancer progression, including breast, prostate, and colorectal cancers, by enhancing proliferation, survival, metastasis, and chemoresistance, and is linked to poor prognosis through NF-κB/STAT3 crosstalk, as well as to insulin resistance and cardiac hypertrophy.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください